Gynecologic cancer in pregnancy.
Korenaga TK, Tewari KS.
Gynecol Oncol. 2020 Jun;157(3):799-809. doi: 10.1016/j.ygyno.2020.03.015. Epub 2020 Apr 5.
Endometriosis-associated cancer.
Guidozzi F.
Climacteric. 2021 Dec;24(6):587-592. doi: 10.1080/13697137.2021.1948994. Epub 2021 Jul 16.
The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.
Kurman RJ, Shih IeM.
Am J Surg Pathol. 2010 Mar;34(3):433-43. doi: 10.1097/PAS.0b013e3181cf3d79.
Coexistence of malignant ovarian Brenner tumor and borderline mucinous cystadenoma, combined with primary uterine corpus endometrioid carcinoma: A case report and literature review.
Zou C, Li Q, Zhao J, Chen Y.
Oncol Lett. 2022 Jun 22;24(2):272. doi: 10.3892/ol.2022.13392. eCollection 2022 Aug.
Intracystic endometrioid borderline tumor.
El Hajj H, Narducci F, McCluggage G, Pasquesoone C.
Int J Gynecol Cancer. 2023 Oct 2;33(10):1663-1665. doi: 10.1136/ijgc-2022-004151.
Comparative study of endometrioid borderline ovarian tumor with and without endometriosis.
Zhang W, Jia S, Xiang Y, Yang J, Jia C, Leng J.
J Ovarian Res. 2018 Aug 11;11(1):67. doi: 10.1186/s13048-018-0440-x.
Atypical Endometriosis: Comprehensive Characterization of Clinicopathologic, Immunohistochemical, and Molecular Features.
Wepy C, Nucci MR, Parra-Herran C.
Int J Gynecol Pathol. 2024 Jan 1;43(1):70-77. doi: 10.1097/PGP.0000000000000952. Epub 2023 Mar 13.
[Endometriosis-related ovarian tumors].
Schmidt D, Ulrich U.
Pathologe. 2014 Jul;35(4):348-54. doi: 10.1007/s00292-014-1949-4.
Management and prognosis of clear cell borderline ovarian tumor.
Uzan C, Dufeu-Lefebvre M, Fauvet R, Gouy S, Duvillard P, Darai E, Morice P.
Int J Gynecol Cancer. 2012 Jul;22(6):993-9. doi: 10.1097/IGC.0b013e3182534acf.
A diagnostic challenge of seromucinous borderline tumor: A case report.
Liu T, Sumida D, Wada T, Maehana T, Yamawaki A, Sugimoto S, Kawahara N, Yoshimoto C, Kobayashi H.
Medicine (Baltimore). 2019 May;98(22):e15707. doi: 10.1097/MD.0000000000015707.
